Higher ERDP scores were significantly associated with developing breast cancer.
Preventive treatments are strongly recommended in women with AH and LCIS.
Postapproval studies are needed to further characterize the risk and long-term safety of immune checkpoint inhibition.
Knowing that food increases the absorption of some therapies presents the possibility of easily — and significantly — lowering treatment costs.
Brentuximab vedotin is an anti-CD30 monoclonal antibody that targets the Reed-Sternberg cells found in patients with classical HL.
It is unclear whether breast cancer screening — and specifically mammography — reduces the likelihood of being diagnosed with advanced-stage disease.
Results from the Prostate Cancer Prevention Trial indicate that the reduced risk for prostate cancer among men assigned to finasteride continued throughout 16 years of follow-up.
Voxtalisib is a potent inhibitor of 4 PI3K isoforms (p110α, p110β, p110γ, and p110δ) and a weaker inhibitor of mTOR.
Colonic stenting can be used as a temporizing measure to help bridge the patient to surgery for optimal timing.
While CDI is becoming more common in all hospitalized patients, patients with cancer appear to be at an elevated risk.
Patients who undergo this cosmetic procedure should be counseled on the increased risk of BIA ALCL.
Larotrectinib may have durable antitumor activity in patients with TRK fusion-positive cancers, regardless of tumor type.
Cancer Therapy Advisor asked Dr Gyawali, who coauthored a viewpoint just published in JAMA Oncology, to discuss the FDA's approval of sunitinib, and whether it is an example of what he calls "regulatory capture" in medicine.
To date, studies of clofarabine in patients with lymphoma have been limited by small patient numbers and myelosuppression toxicities.
Close to 60% of all patients with VHL will develop RCC or renal cysts.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Rectal Cancer: Adjuvant Chemotherapy May Improve OS After pCR
- Breast Cancer: Determining the Best Diet for Disease Prevention
- Hormone Therapy for Breast Cancer May Cause Diabetes
- Post-Oophorectomy Estrogen Therapy May Not Increase Breast Cancer Risk in BRCA1 Carriers
- Carboxyamidotriazole Orotate With Temozolomide May Be Active Against Glioblastoma